Expression of xenobiotic metabolizing enzymes in breast cancer

The Journal of Pathology
G I MurrayM D Burke

Abstract

We have studied the expression of different xenobiotic metabolizing enzymes in primary operable breast cancer of no special type. The expression of two forms of cytochrome P450, microsomal epoxide hydrolase, and three classes of glutathione S-transferase was investigated using immunohistochemistry. The tumours were characterized by consistent expression of microsomal epoxide hydrolase and by variable expression of the two forms of cytochrome P450 and the three types of glutathione S-transferase. Cytochrome P450 1A and cytochrome P450 3A were identified in 39 and 22 per cent of tumours, respectively. In each case, immunostaining was present only in areas of invasive carcinoma. Epoxide hydrolase was identified in 89 per cent of tumours and glutathione S-transferases pi, mu, and alpha were identified in 56, 65, and 44 per cent of tumours, respectively. Immunoreactivity for epoxide hydrolase and glutathione S-transferases was identified in both tumours and non-neoplastic breast tissue. The presence of different xenobiotic metabolizing enzymes may have a role in determining the intrinsic drug resistance of breast cancer to a variety of anti-cancer drugs, and the expression of these enzymes can readily be assessed using immunohistoch...Continue Reading

References

Sep 28, 1995·Biochemical Pharmacology·G I Murray, M D Burke
Dec 4, 2003·Cancer Letters·N KapucuogluMumtaz Iscan
Jan 5, 2002·Biochemical Pharmacology·Marie StiborováEva Frei
Dec 9, 1998·International Journal of Radiation Oncology, Biology, Physics·S M RaleighL H Patterson
Jan 5, 2002·Breast Cancer Research and Treatment·Mumtaz IscanH Raunio
May 19, 2006·Pharmacogenetics and Genomics·Jatinder K LambaErin G Schuetz
Dec 1, 1995·British Journal of Clinical Pharmacology·K T KivistöM Eichelbaum
Nov 1, 1996·Alcoholism, Clinical and Experimental Research·K W Singletary
May 1, 1994·Gut·G I MurrayM D Burke
May 10, 2000·Clinical Pharmacokinetics·A V Boddy, S M Yule
Sep 1, 2008·Interdisciplinary Toxicology·Jitka PoljakováMarie Stiborová
Apr 8, 2006·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Jitka PoljakováMarie Stiborová
Jun 8, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nagendra Kumar KaushikEun Ha Choi
Jan 1, 1996·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·P FritzH K Kroemer
Apr 22, 2015·International Journal of Oncology·Xia LiuFuqiang Yin
Nov 6, 2003·International Journal of Cancer. Journal International Du Cancer·Marie StiborováEva Frei
Nov 1, 2007·Environmental Toxicology and Pharmacology·Nancy Hernández-MartínezA Vences-Mejía
Jul 1, 2005·Environmental Toxicology and Pharmacology·A Vences-MejíaJ J Espinosa-Aguirre
Dec 7, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Rafiaa ValjiSunita Vohra
Apr 17, 1999·British Journal of Cancer·G I MurrayW T Melvin
May 25, 2006·International Journal of Cancer. Journal International Du Cancer·Susanne HaasHans-Peter Fischer
Oct 1, 1994·The Journal of Pathology·J A McKayM D Burke
Sep 1, 1993·The Journal of Pathology·G I MurrayM D Burke
Oct 1, 1995·The Journal of Pathology·G I MurrayM D Burke
Aug 19, 2010·Histopathology·G I MurraySteven D Heys
Sep 12, 2002·Drug Metabolism and Drug Interactions·P P MaliakalS Wanwimolruk
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P FritzU M Zanger

Citations

Feb 1, 1992·Carcinogenesis·G I MurrayM D Burke
Jan 1, 1991·Pharmacology & Therapeutics·M A GrahamD J Kerr
Jan 1, 1991·Annual Review of Pharmacology and Toxicology·J C McGiff
Jan 1, 1990·Cancer Investigation·W T BellamyR T Dorr
Apr 1, 1991·British Journal of Cancer·K PyykköT Perkiö
Jun 1, 1991·British Journal of Cancer·G I MurrayM D Burke
Jan 1, 1990·Pharmacology & Therapeutics·F J Gonzalez
Jan 1, 1989·Cancer Treatment and Research·R C Young
Jan 1, 1989·Drug Metabolism Reviews·G A Le Blanc, D J Waxman
Sep 1, 1989·British Journal of Cancer·A D LewisC R Wolf
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J A MoscowK H Cowan
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K H CowanC E Myers
Feb 1, 1984·The Australian and New Zealand Journal of Surgery·C W Elston
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A Sevanian, A R Peterson
Jan 1, 1980·Annual Review of Pharmacology and Toxicology·A Y Lu, G T Miwa

Related Concepts

Immunohistochemistry
Immunoreactivity
Enzymes, antithrombotic
Cytochrome P450
Invasive Carcinoma
Oxidase
Neoplasms
Tumor Lysis Syndrome
Breast Tissue Sample
Immunocytochemistry

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.